Wugen

0 followers


Wugen is a clinical stage immuno-oncology cell therapy company, developing off-the-shelf NK and CAR-T cell therapies for the treatment of both solid tumor and heme malignancies.

Industries

Employees

51-200

Links

Org chart

Kumar Srinivasan
President & CEO

Kumar Srinivasan

Collapse
Ayman Kabakibi
COO & EVP, R&D
Brunda Tumala
Director CMC Process Development
Jonathan Miller
Sr. Director, Head Of Supply Chain & Procurement
Kenneth Jacobs
VP Pharmacovigilance And Clinical Development
Laura Simpson PhD
Vp, Head Of Regulatory Affairs
Matthew Cooper
Chief Scientific Officer
Patrick Valme
Director Of Information Technology
Preeta Dasgupta
Senior Director Regulatory Affairs
Rachel Langland
Director, Analytical Development
Sarah Perdue
Associate Director, Operational Excellence
Carol Weiss
Senior Director, Quality Assurance
Jimmy Pham
Senior Associate Scientist
Keith Vendola
Chief Financial Officer